Acute Respiratory Failure Requiring BiPAP

Non-invasive positive pressure ventilation for COPD, OHS, CHF, or neuromuscular disease — reduces intubation rate and improves survival

Symptoms / Associated Sx

  • Progressive dyspnea, tachypnea (>25 breaths/min)

  • Accessory muscle use, paradoxical breathing (diaphragm failure)

  • Hypercapnia (PaCO2 >45 with pH <7.35) — CO2 retention

  • Hypoxia (SpO2 <88% on room air)

  • Altered mentation from hypercapnia (CO2 narcosis — drowsiness, confusion)

  • Inability to speak in full sentences

Denies

  • Respiratory arrest or apnea (contraindication to NIV — requires intubation)

  • Active vomiting, upper GI bleeding (aspiration risk — relative contraindication to NIV)

  • Altered mentation severe enough to not cooperate (cannot maintain mask seal)

  • Recent upper airway/GI surgery (contraindication to positive pressure)

Social History (SHx)

Known COPD + prior BiPAP use, OHS/severe obesity (BMI >35), CHF with prior pulmonary edema, neuromuscular disease (ALS, myasthenia gravis, GBS), prior intubations, home CPAP/BiPAP use, baseline ABG values.

Main Etiology

  • COPD exacerbation with hypercapnic respiratory failure (most evidence for NIV benefit)

  • Obesity hypoventilation syndrome (OHS) — BMI >30 + PaCO2 >45 during wakefulness without other cause

  • CHF with acute cardiogenic pulmonary edema (reduces preload + afterload; improves oxygenation)

  • Neuromuscular disease (ALS, GBS, MG — respiratory muscle weakness; use NIV to avoid intubation)

  • Post-extubation respiratory failure (bridging to extubation success)

Most Common DDx

  • Need for intubation vs. NIV (altered mentation + inability to cooperate + hemodynamic instability + apnea → intubation; not candidates for NIV)

  • COPD vs. OHS (COPD: emphysematous changes, smoking history, FEV1 reduced; OHS: BMI >35, hypercapnia in waking state without COPD-level obstruction, better response to weight loss)

  • Hypoxemic vs. hypercapnic failure (NIV works best for hypercapnic; HFNC works better for pure hypoxemic failure without hypercapnia)

  • Central hypoventilation (obesity-related vs. drug-induced vs. CNS lesion — CT head if sudden onset without clear etiology)

  • Neuromuscular weakness (GBS, MG crisis — check NIF <-25 cmH2O → impending failure; NIV as bridge to treatment)

DATA

  • ABG (pH, PaCO2, PaO2, HCO3 — respiratory acidosis; chronic vs. acute hypercapnia: bicarbonate compensation)

  • SpO2 continuous

  • CBC, BMP (electrolytes — hypokalemia worsens respiratory muscle function)

  • BNP (CHF component)

  • CXR (bilateral pulmonary edema; infiltrates; hyperinflation; effusions)

  • EKG (right heart strain, arrhythmias)

  • Negative inspiratory force (NIF) — if neuromuscular cause suspected; NIF <-25 cmH2O or FVC <20 mL/kg → impending respiratory failure

  • Serum bicarbonate (elevated chronically = chronic CO2 retainer; sudden acute rise = acute decompensation)

  • Thyroid function (hypothyroidism → hypoventilation)

Home Meds

  • Home CPAP/BiPAP settings (OHS/OSA — use home settings initially; escalate IPAP as needed)

  • Opioids and benzodiazepines (respiratory suppressants — hold; reverse with naloxone/flumazenil if opioid/benzo-induced hypoventilation)

  • Inhalers (COPD — continue and escalate bronchodilators)

  • Diuretics (CHF — IV furosemide concurrently with BiPAP)

Plan

  • BiPAP (IPAP/EPAP) settings:

    • Initial: IPAP 10–14 cmH2O, EPAP 4–6 cmH2O (inspiratory pressure support = IPAP − EPAP; target ~8–10 cmH2O)

    • OHS: IPAP 16–20 cmH2O, EPAP 6–8 cmH2O (higher pressures needed for obesity)

    • CHF pulmonary edema: CPAP 5–10 cmH2O or IPAP/EPAP 12/5 cmH2O (CPAP as effective as BiPAP in most CHF)

    • Titrate FiO2 to target SpO2 88–92% (COPD) or ≥92% (CHF/OHS)

    • Reassess ABG at 1–2h: pH improving and PaCO2 falling = responding; pH not improving = escalate IPAP or consider intubation

  • COPD hypercapnic failure:

    • BiPAP + bronchodilators + steroids + antibiotics (see COPD section)

    • Continue NIV until: pH >7.35, PaCO2 decreasing, RR <25, patient comfortable

  • OHS acute decompensation:

    • BiPAP at high settings; may need 20/8 cmH2O; allow CO2 to normalize slowly (not rapidly — hypoventilation is chronic)

    • Avoid sedatives/opioids; position upright

    • Consider AVAPS (average volume-assured pressure support) for OHS — targets set tidal volume

  • CHF pulmonary edema:

    • BiPAP or CPAP + IV furosemide 40–80 mg IV + IV nitroglycerin if SBP >110 (reduces preload + afterload)

    • Rapid improvement expected within 1–2h

  • Neuromuscular disease:

    • NIV as bridge; treat underlying cause (plasma exchange in GBS; pyridostigmine/IVIG in MG)

    • Monitor NIF q4h; if NIF <-20 cmH2O → intubation discussion

  • Contraindications to NIV → intubation: pH <7.20 with worsening despite 1h BiPAP, cardiac arrest, hemodynamic instability, facial anatomy preventing seal, inability to clear secretions

  • Serial ABG q1–2h while on NIV; reassess at 2h for response

  • Daily CBC, BMP; trend CO2 and pH response

  • Pulmonology or critical care consult for all patients on BiPAP

  • PT/OT — respiratory therapy; breathing exercises; gradually wean NIV as tolerated

  • Discharge: Home BiPAP/CPAP prescription (new or adjusted); outpatient sleep study if OSA/OHS not yet formally diagnosed; pulmonology follow-up within 2 weeks; weight loss counseling (OHS); optimize COPD/CHF regimen

Red Flags

  • pH <7.20 after 1–2h BiPAP without improvement → intubation urgently

  • Altered mentation deteriorating on BiPAP (CO2 narcosis progressing) → intubation for airway protection

  • NIF <-20 cmH2O in neuromuscular disease → impending respiratory arrest → early intubation discussion; do not wait for respiratory arrest

  • Hemodynamic instability on BiPAP → positive pressure reduces venous return → may worsen in cardiogenic shock; vasopressors + ICU

  • Mask intolerance, agitation, vomiting on BiPAP → high aspiration risk → intubate

Senior IM Resident Pearls

  • BiPAP is the standard of care for COPD hypercapnic failure — reduces intubation rate from ~50% to ~25% and ICU mortality; start early (pH 7.30–7.35) for best results

  • CPAP vs. BiPAP in CHF: CPAP 5–10 cmH2O is as effective as BiPAP for most cardiogenic pulmonary edema; BiPAP preferred if hypercapnia is also present

  • OHS needs higher IPAP than COPD — these patients have chest wall restriction from obesity + upper airway obstruction; AVAPS mode targets tidal volume and adjusts pressures automatically

  • Never sedate a BiPAP patient to improve compliance — sedation removes respiratory drive and converts hypercapnia into CO2 narcosis; if patient cannot cooperate, they need intubation

  • Common mistake: Reassurance when ABG improves slightly on BiPAP without watching the trend — a pH of 7.28 improving to 7.30 over 2h is acceptable; if pH is 7.30 and trending down after 1h, intubate before respiratory arrest

Acute Respiratory Failure Requiring BiPAP — Senior Resident Rapid Recall

Presentation

Dyspnea + tachypnea + hypercapnia (PaCO₂ >45) + respiratory acidosis

  • Accessory muscle use

  • Unable to speak full sentences

  • Hypoxia

  • CO₂ narcosis (confusion, drowsiness)

  • Paradoxical breathing (fatigue)

Key Findings → Likely Diagnosis

  • Hypercapnia + wheezing + smoking history → COPD

  • BMI >35 + chronic hypercapnia → OHS

  • Pulmonary edema + BNP ↑ → CHF

  • Weakness + NIF <-25 → Neuromuscular disease

  • Apnea or severe AMS → Needs intubation, NOT BiPAP

Key Labs

  • ABG: pH <7.35 + PaCO₂ >45

  • HCO₃ ↑ → Chronic CO₂ retainer

  • BNP ↑ → CHF

  • NIF <-25 cmH₂O → Impending respiratory failure

  • FVC <20 mL/kg → Consider intubation

Key Imaging

  • Hyperinflation → COPD

  • Pulmonary edema → CHF

  • Infiltrate → Pneumonia trigger

  • Effusion → CHF/other cause

Who Gets BiPAP?

✅ COPD exacerbation
✅ OHS
✅ CHF pulmonary edema
✅ Neuromuscular weakness (bridge)

❌ Respiratory arrest
❌ Severe AMS/uncooperative
❌ Active vomiting
❌ Cannot protect airway
❌ Hemodynamic instability

Initial BiPAP Settings

  • COPD: 10/5 → titrate

  • OHS: 16–20 / 6–8

  • CHF: CPAP 5–10 or BiPAP 12/5

Reassess in 1–2 Hours

Good Response

  • pH ↑

  • PaCO₂ ↓

  • RR ↓

  • Less WOB

Bad Response

  • pH worsening

  • PaCO₂ rising

  • Mental status worsening

→ Intubate

Medications

COPD

  • Duonebs

  • Prednisone 40 mg daily

  • Antibiotics if indicated

CHF

  • Furosemide 40–80 mg IV

  • Nitroglycerin if SBP >110

OHS

  • Avoid opioids/benzos

  • Weight loss long term

Opioid overdose

  • Naloxone

Myasthenia Gravis

  • IVIG/PLEX

GBS

  • IVIG/PLEX

ICU / Intubation Triggers

  • pH <7.20 despite BiPAP

  • Worsening hypercapnia

  • Progressive AMS

  • NIF <-20

  • Respiratory arrest

  • Hemodynamic instability

  • Cannot tolerate mask

Most Tested Pearls

  • BiPAP = standard of care for COPD hypercapnic respiratory failure

  • HFNC is better for pure hypoxemic respiratory failure

  • CPAP works nearly as well as BiPAP in CHF

  • OHS requires higher pressures than COPD

  • Never sedate a patient to tolerate BiPAP

  • If they can't tolerate BiPAP, they probably need intubation

One-Line Memory Rules

  • pH <7.35 + PaCO₂ >45 → Hypercapnic respiratory failure

  • COPD + hypercapnia → BiPAP

  • BMI >35 + chronic CO₂ retention → OHS → Higher BiPAP settings

  • Pulmonary edema + respiratory distress → CPAP/BiPAP + IV Lasix

  • NIF <-25 → Impending respiratory failure

  • NIF <-20 → Intubation discussion

  • pH improving after 1–2 hr = BiPAP working

  • pH worsening after 1–2 hr = Intubate

  • AMS + hypercapnia = CO₂ narcosis

  • Apnea, vomiting, or inability to protect airway = NOT a BiPAP candidate

  • Never sedate a BiPAP patient to improve compliance